Boost the growth of the global biopsy devices market at a CAGR of 6.80% during the forecast period from 2022 to 2030

Market Research Future (MRFR) has published a cooked research report on the “Global Biopsy Devices Market”that contains the information from 2022 to 2030.

MRFR recognizes the following companies as the key players in the global biopsy devices market— Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US) and Trivitron Healthcare (India).

Biopsy Devices Market Highlights

The global biopsy devices market is expected to register a CAGR of 6.80% during the forecast period and is expected to hit USD 2.4 billion by 2030.

A biopsy is a medical test commonly performed by a surgeon, an interventional radiologist, or an interventional cardiologist. The process involves the extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is then fixed, dehydrated, embedded, sectioned, stained, and mounted before it is generally examined under a microscope by a pathologist; it may also be analyzed chemically. Key factors such as the increasing prevalence of cancer, increasing preference for minimally invasive surgeries, and rise in government initiatives are boosting market growth. The lack of proper healthcare infrastructure and the high cost of biopsy devices may hamper the market growth. The adoption of robotic-assisted biopsy systems and the approval and launch of new products by key players will create lucrative opportunities for the players operating in the global biopsy devices market.

Segment Analysis

The global biopsy devices market has been divided based on product type, application, guidance technique, and end user.

The market, based on product type, has been segmented into biopsy guns, biopsy guidance system, biopsy needles, biopsy forceps, localization wires, and others.

Based on application, the biopsy devices market has been divided into breast biopsy, prostate biopsy, liver biopsy, lung biopsy, gynecological biopsy, and others.

The market, based on guidance technique, has been segmented into ultrasound-guided biopsy, stereotactic guided biopsy, MRI-guided biopsy, CT guided biopsy, and others.

The market, based on end user, has been segmented into hospitals & clinics, diagnostic & imaging centers, academic & research institutes, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Biopsy Devices Market Research Report

Regional Analysis

The global biopsy devices market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. The North America market is further divided into US, Canada, and Mexico. The Europe biopsy devices market has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe. The biopsy devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, and the rest of Asia-Pacific. The biopsy devices market in the Rest of the World has been segmented into the Middle East, Africa, and Latin America

North America is expected to dominate the biopsy devices market due to the presence of well-established market players in the nation, rising market demand for disposable products, and an inclination for minimally invasive procedures. Additionally, government initiatives for diagnosis are also boosting the market.

Europe is held a significant share of the global Biopsy devices market. The greater reimbursement coverage for biopsy procedures, rising use of high-end devices, and favourable demographics, as well as the expansion of national cancer screening programmes, are driving the biopsy devices market in Europe.

Asia-Pacific is expected to be the fastest-growing for global biopsy devices market. This is due to the rising incidence of cancer, the big populations in nations like China and India, the improved healthcare infrastructure, and increased healthcare spending and government initiatives.

The biopsy devices market in the rest of the world is growing slowly. The countries in these regions have experienced slower growth in the biopsy devices market due to a lack of medical facilities, underdeveloped regulations, and lower adoption rates.

Key Findings of the Study

• The global biopsy devices market is expected to reach USD 4.22 billion by 2030 at a CAGR of 7.00% during the forecast period.


• The North America region accounted for the largest share of the global market, owing to high market penetration rates of cutting-edge products, like vacuum-assisted biopsy systems, and a quickly rising market demand for disposable products.


• Based on product type, the biopsy guns segment had the largest share in 2022.


• Based on application, the breast biopsy segment held the largest share in 2022.


• Based on guidance technique, the CT-guided biopsy segment held the largest market in 2022.


• Based on end user, the hospitals & clinics segment held the largest market in 2022.